ProfileGDS4132 / 235521_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 44% 54% 50% 44% 41% 47% 44% 65% 55% 47% 53% 64% 54% 64% 44% 52% 55% 46% 51% 59% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101116.78244
GSM201543Muscle PCOS pioglitazone 121139.13254
GSM201544Muscle PCOS pioglitazone 161135.81350
GSM201545Muscle PCOS pioglitazone 201122.94244
GSM201829Muscle PCOS pioglitazone 231114.56841
GSM201830Muscle PCOS pioglitazon 251130.97447
GSM201831Muscle PCOS pioglitazone 271116.32744
GSM201832Muscle PCOS pioglitazone 31180.33665
GSM201833Muscle PCOS pioglitazone 41139.60255
GSM201834Muscle PCOS pioglitazone 81123.20247
GSM201835Muscle PCOS after pioglitazone 102130.36253
GSM201836Muscle PCOS after pioglitazone 122177.24264
GSM201837Muscle PCOS after pioglitazone 162129.98654
GSM201838Muscle PCOS after pioglitazone 202177.50364
GSM201839Muscle PCOS after pioglitazone 232107.05444
GSM201840Muscle PCOS after pioglitazone 252136.65152
GSM201841Muscle PCOS after pioglitazone 272135.14355
GSM201842Muscle PCOS after pioglitazone 3299.614246
GSM201843Muscle PCOS after pioglitazone 42130.7951
GSM201844Muscle PCOS after pioglitazone 82162.74759